Cleared Traditional

BIODESIGN ONLAY DURAL GRAFT OR BIODESIGN DURAPLASTY GRAFT

K131015 · Cook Biotech, Inc. · Neurology
Oct 2013
Decision
180d
Days
Class 2
Risk

About This 510(k) Submission

K131015 is an FDA 510(k) clearance for the BIODESIGN ONLAY DURAL GRAFT OR BIODESIGN DURAPLASTY GRAFT, a Dura Substitute (Class II — Special Controls, product code GXQ), submitted by Cook Biotech, Inc. (West Lafayetta, US). The FDA issued a Cleared decision on October 8, 2013, 180 days after receiving the submission on April 11, 2013. This device falls under the Neurology review panel. Regulated under 21 CFR 882.5910.

Submission Details

510(k) Number K131015 FDA.gov
FDA Decision Cleared SESE
Date Received April 11, 2013
Decision Date October 08, 2013
Days to Decision 180 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code GXQ — Dura Substitute
Device Class Class II — Special Controls
CFR Regulation 21 CFR 882.5910